Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05535283 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessing Clinical Trial Experiences of Patients With Osteosarcoma

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 2, 2024 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Oct 2024 to Oct 2025 Start date: Oct 2023 to Oct 2024 · Completion date: Oct 2025 to Oct 2026v3 Show 2 more changesShow less
    • Start date: Oct 2023 to Oct 2024
    • Completion date: Oct 2025 to Oct 2026
  2. Primary completion date: Oct 6, 2023 to Oct 2024 Start date: Oct 6, 2022 to Oct 2023 · Completion date: Oct 6, 2024 to Oct 2025v2 Show 2 more changesShow less
    • Start date: Oct 6, 2022 to Oct 2023
    • Completion date: Oct 6, 2024 to Oct 2025
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Clinical study participation has historically been heavily biased toward specific demographics. Several people will be invited to enroll in this study so that it may collect a variety of data about osteosarcoma clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal. People with osteosarcoma who are invited to take part in medical research will benefit from the analysis of the data.
Trial Details
NCT Number NCT05535283
Lead Sponsor Power Life Sciences Inc.
Conditions Osteosarcoma
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov